World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
95
Citations
47125
World Ranking
9889
National Ranking
5089

Overview

David G. Warnock is affiliated with the University of Alabama at Birmingham in the United States. Their research primarily focuses on Medicine and Biochemistry, Genetics and Molecular Biology, with particular emphasis on Physiology, Epidemiology, Organic Chemistry, Molecular Biology, and Rheumatology as key subfields.

The scientist's work centers around topics such as Lysosomal Storage Disorders Research, Carbohydrate Chemistry and Synthesis, Trypanosoma species research and implications, Glycogen Storage Diseases and Myoclonus, Enzyme Production and Characterization, Ginkgo biloba and Cashew Applications, and Cellular transport and secretion.

Warnock has contributed to multiple publications in prominent venues including:

  • Molecular Genetics and Metabolism
  • Journal of Medical Genetics
  • The Nephron journals
  • Journal of the American Society of Nephrology
  • Genetics in Medicine Open

Among recent papers associated with or relevant to their collaborative work are:

  • Lyso-Gb3 associates with adverse long-term outcome in patients with Fabry disease, 2021, Journal of Medical Genetics
  • Use of a rare disease registry for establishing phenotypic classification of previously unassigned GLA variants: a consensus classification system by a multispecialty Fabry disease genotype-phenotype workgroup, 2020, Journal of Medical Genetics
  • A new approach to identifying patients with elevated risk for Fabry disease using a machine learning algorithm, 2021, Orphanet Journal of Rare Diseases
  • Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study, 2023, Journal of Medical Genetics
  • Early indicators of disease progression in Fabry disease that may indicate the need for disease-specific treatment initiation: findings from the opinion-based PREDICT-FD modified Delphi consensus initiative, 2020, BMJ Open

David G. Warnock's frequent collaborators include researchers such as Derralynn Hughes, Eric Wallace, Raul Chertkoff, Camilla Tøndel, and Sari Alon, reflecting a diverse and multidisciplinary engagement within their research community.

Best Publications

  • Acute Kidney Injury Network: Report of an Initiative to Improve Outcomes in Acute Kidney Injury

    Ravindra L Mehta;John A Kellum;Sudhir V Shah;Bruce A Molitoris

  • Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis.

    Kunihiro Matsushita;Marije van der Velde;Brad C. Astor;Mark Woodward

  • Liddle's syndrome: heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel

    Richard A. Shimkets;David G. Warnock;Christopher M. Bositis;Carol Nelson-Williams

  • Bardoxolone Methyl and Kidney Function in CKD with Type 2 Diabetes

    Pablo E. Pergola;Philip Raskin;Robert D. Toto;Colin J. Meyer

  • Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.

    Kunihiro Matsushita;Bakhtawar K. Mahmoodi;Bakhtawar K. Mahmoodi;Mark Woodward;Jonathan R. Emberson

  • Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data.

    Kunihiro Matsushita;Josef Coresh;Yingying Sang;John Chalmers

  • Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial

    Maryam Banikazemi;Jan Bultas;Stephen Waldek;William R. Wilcox

  • Prevalence, treatment, and control of hypertension in chronic hemodialysis patients in the United States.

    Rajiv Agarwal;Allen R Nissenson;Daniel Batlle;Daniel W Coyne

  • Females with Fabry disease frequently have major organ involvement : Lessons from the Fabry Registry

    William R. Wilcox;William R. Wilcox;João Paulo Oliveira;Robert J. Hopkin;Alberto Ortiz

  • Acute Kidney Injury and Mortality in Hospitalized Patients

    Henry E. Wang;Paul Muntner;Glenn M. Chertow;David G. Warnock

  • Fabry disease: guidelines for the evaluation and management of multi-organ system involvement.

    Christine M Eng;Dominique P Germain;Maryam Banikazemi;David G Warnock

  • Detection of chronic kidney disease with creatinine, cystatin C, and urine albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality.

    Carmen A. Peralta;Michael G. Shlipak;Suzanne Judd;Mary Cushman

  • The global burden of chronic kidney disease: estimates, variability and pitfalls

    Richard J. Glassock;David G. Warnock;Pierre Delanaye

  • Liddle's Syndrome Revisited -- A Disorder of Sodium Reabsorption in the Distal Tubule

    Mauricio Botero-Velez;John J. Curtis;David G. Warnock

  • Kidney function and cognitive impairment in US adults: the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.

    Manjula Kurella Tamura;Virginia Wadley;Virginia Wadley;Kristine Yaffe;Leslie A. McClure

  • Fabry disease: progression of nephropathy, and prevalence of cardiac and cerebrovascular events before enzyme replacement therapy

    Raphael J. Schiffmann;David G. Warnock;Maryam Banikazemi;Jan Bultas

  • Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

    Dominique P Germain;Joel Charrow;Robert J Desnick;Nathalie Guffon

  • Time-Dependent Associations between Iron and Mortality in Hemodialysis Patients

    Kamyar Kalantar-Zadeh;Deborah L. Regidor;Charles J. McAllister;Beckie Michael

  • Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction

    Britt B. Newsome;David G. Warnock;William M. McClellan;Charles A. Herzog

  • Agalsidase-Beta Therapy for Advanced Fabry Disease

    Maryam Banikazemi;Jan Bultas;Stephen Waldek;William R. Wilcox

Frequent Co-Authors

Paul Muntner
Paul Muntner University of Alabama at Birmingham
William M. McClellan
William M. McClellan Emory University
Christoph Wanner
Christoph Wanner University of Würzburg
William R. Wilcox
William R. Wilcox Emory University
Alberto Ortiz
Alberto Ortiz Autonomous University of Madrid
George Howard
George Howard University of Alabama at Birmingham
Mary Cushman
Mary Cushman University of Vermont
Daniel G. Bichet
Daniel G. Bichet University of Montreal
Ravindra L. Mehta
Ravindra L. Mehta University of California, San Diego
Monika M. Safford
Monika M. Safford Cornell University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in a medical career but want to explore alternative or related options, there are several online degrees and pathways to consider. One popular choice is online lpn programs, which provide a fast and flexible route into practical nursing roles. For nurses looking to specialize further, the shortest post master's pmhnp online programs offer a streamlined pathway to become a Psychiatric Mental Health Nurse Practitioner.

Not all healthcare roles require direct patient care. A bachelors in health administration can set you on course for leadership roles within clinics, hospitals, or managed care organizations. For those seeking advanced positions, there are also online mha programs affordable that focus on strategic management and operational leadership in healthcare settings.

Each of these online degree options offers valuable flexibility and can help you enter or advance in the rapidly growing healthcare field, even if you want an alternative to the traditional MD route.

Best Scientists Citing David G. Warnock

Trending Scientists